5295 Westview Drive, Suite 275
Tel: +1 301-200-5366
3 articles about RoosterBio, Inc.
Horizon Therapeutics’ Bill Rees spoke to BioSpace about the scientific discovery and collaboration potential of its new Rockville, Maryland site, which is expected to open in 2024.
RoosterBio Partners with Senti Biosciences to Rapidly Translate Gene Circuit Cell Therapy into the ClinicCollaboration leverages cGMP clinical hMSC systems to accelerate gene modified cell therapy for solid tumors.
RoosterBio Inc. announces a clinical supply and manufacturing collaboration agreement with pioneering gene circuit company Senti Biosciences, Inc. (Senti) to accelerate the clinical translation of Senti’s gene-modified cell therapies for ovarian cancer and other solid tumor indications. The collaboration will leverage RoosterBio’s human mesenchymal stem/stromal cell (hMSC) bioprocess systems, rapid product and process development platform, and
The start of 2020 has also brought the need for some companies in the pharma industry to acquire the next size up in building space as they expand their employee headcount.